These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1461622)

  • 1. Megestrol acetate in the treatment of metastatic carcinoma of the prostate.
    Venner P
    Oncology; 1992; 49 Suppl 2():22-7. PubMed ID: 1461622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic options in treatment of advanced carcinoma of the prostate.
    Venner PM
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):73-7. PubMed ID: 2259929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megestrol acetate plus low-dose estrogen in the management of advanced prostatic carcinoma.
    Geller J
    Urol Clin North Am; 1991 Feb; 18(1):83-91. PubMed ID: 1825145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megestrol acetate in relapsed carcinoma of prostate.
    Daniel F; MacLeod PM; Tyrrell CJ
    Br J Urol; 1990 Mar; 65(3):275-7. PubMed ID: 2186841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: outcome results of RTOG 83-07.
    Pilepich MV; Buzydlowski JW; John MJ; Rubin P; McGowan DG; Marcial VA
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):175-80. PubMed ID: 7721614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of megestrol acetate for metastatic carcinoma of the prostate.
    Crombie C; Raghavan D; Page J; Woods R; Dalley D; Devine R; Rosen M
    Br J Urol; 1987 May; 59(5):443-6. PubMed ID: 3594101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megestrol acetate used as primary hormonal therapy in stage D prostatic cancer.
    Bonomi P; Pessis D; Bunting N; Block M; Anderson K; Wolter J; Rossof A; Slayton R; Harris J
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):36-9. PubMed ID: 3975650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Megestrol acetate plus minidose diethylstilbestrol in the treatment of carcinoma of the prostate.
    Venner PM; Klotz PG; Klotz LH; Stewart DJ; Davis IR; Orovan WL; Ramsey EW
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):62-7. PubMed ID: 3285485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dramatic prostate specific antigen decrease in response to discontinuation of megestrol acetate in advanced prostate cancer: expansion of the antiandrogen withdrawal syndrome.
    Dawson NA; McLeod DG
    J Urol; 1995 Jun; 153(6):1946-7. PubMed ID: 7538601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal cytoreduction in locally advanced carcinoma of the prostate treated with definitive radiotherapy: preliminary results of RTOG 83-07.
    Pilepich MV; Krall JM; John MJ; Rubin P; Porter AT; Marcial VA; Martz KL
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):813-7. PubMed ID: 2646266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical castration of males with megestrol acetate and small doses of diethylstilbestrol.
    Geller J; Albert J; Yen SS; Geller S; Loza D
    J Clin Endocrinol Metab; 1981 Mar; 52(3):576-80. PubMed ID: 6161942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Megace, Stilphostrol, Megace plus DES, or streptozotocin in metastatic prostatic cancer in patients with hormonal failure and prior radiotherapy.
    McLeod DG; Murphy GP; Priore R
    Urology; 1988 Nov; 32(5):431-6. PubMed ID: 2973171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megestrol acetate: clinical experience.
    Schacter L; Rozencweig M; Canetta R; Kelley S; Nicaise C; Smaldone L
    Cancer Treat Rev; 1989 Mar; 16(1):49-63. PubMed ID: 2471590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiandrogenic drugs.
    McLeod DG
    Cancer; 1993 Feb; 71(3 Suppl):1046-9. PubMed ID: 8428326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for carcinoma of the prostate.
    Smith JA
    J Urol; 1994 Jul; 152(1):132-4. PubMed ID: 8201642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megestrol acetate for treatment of advanced carcinoma of the prostate.
    Johnson DE; Kaesler KE; Ayala AG
    J Surg Oncol; 1975; 7(1):9-15. PubMed ID: 1177459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate.
    Patel SR; Kvols LK; Hahn RG; Windschitl H; Levitt R; Therneau T
    Cancer; 1990 Aug; 66(4):655-8. PubMed ID: 2201425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical castration using megestrol acetate and minidose estrogen.
    Johnson DE; Babaian RJ; Swanson DA; von Eschenbach AC; Wishnow KI; Tenney D
    Urology; 1988 May; 31(5):371-4. PubMed ID: 3284149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of castration compared with total androgen blockade on tissue dihydrotestosterone (DHT) concentration in benign prostatic hyperplasia (BPH).
    Geller J; Albert J
    Urol Res; 1987; 15(3):151-3. PubMed ID: 3629749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megestrol acetate: a new role in the treatment of metastatic breast cancer.
    Allegra JC
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):45-7. PubMed ID: 3589707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.